Cargando…
Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL-17
Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on the levels of serum IL-17 were investigated. A retrospective analysis was performed on 129 patients who had metastatic gastric cancer after first-line chemotherapy and were treated in Xiangyang No. 1 People's...
Autores principales: | Chen, Ran, Chen, Qi-Tian, Dong, You-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507486/ https://www.ncbi.nlm.nih.gov/pubmed/31186764 http://dx.doi.org/10.3892/ol.2019.10270 |
Ejemplares similares
-
The prognostic value of baseline hematological parameters of peripheral blood in metastatic gastric cancer treated with apatinib
por: Yang, Jin-Ru, et al.
Publicado: (2022) -
Apatinib inhibits gastric carcinoma development by regulating the expression levels of IL-17 via the Bax/Bcl-2 signaling pathway
por: Wang, Tianxi, et al.
Publicado: (2021) -
Apatinib Treatment in Metastatic Gastrointestinal Stromal Tumor
por: Cai, Zhaolun, et al.
Publicado: (2019) -
Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer
por: Li, Ningning, et al.
Publicado: (2020) -
Efficacy and toxicity of apatinib combined with or without chemotherapy for patients with advanced or metastatic chemotherapy-refractory gastric adenocarcinoma: A prospective clinical study
por: Guo, Yesong, et al.
Publicado: (2019)